Maverick Capital’s AngioDynamics ANGO Stock Holding History

Maverick Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,324	Closed	-$117K	–	640
2021 Q2	$117K	Buy	+4,324	New	+$106K	﹤0.01%	552

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Maverick Capital's ANGO Position: Q3 2021 in Review

Maverick Capital sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 4,324 shares — an estimated $117K sold.

Maverick Capital first reported a position in ANGO in Q2 2021 and held it in 1 quarter. The position peaked at $117K in Q2 2021. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

Maverick Capital reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
Maverick Capital sold 4,324 AngioDynamics shares in Q3 2021, an estimated $117K.
Maverick Capital first reported a position in AngioDynamics in Q2 2021 and held it in 1 quarter.
Maverick Capital's AngioDynamics position peaked at $117K in Q2 2021.
156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on Maverick Capital's 13F filing for Q3 2021, filed 15 Nov 2021.